Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• The cell cycle involves distinct phases (G1, S, M, G2) where cell proliferation occurs.
• Ki-67 is a reliable marker for quantifying cells in these proliferative phases.
• Multiple sclerosis (MS) is a chronic neurological disease characterized by demyelination and neuroinflammation.

Purpose of the Study:

• To quantify glial cell proliferation in brain tissue from MS patients and controls using Ki-67 immunohistochemistry.
• To investigate the lineage of proliferating glial cells within MS lesions.
• To assess if glial proliferation differs between active and chronic MS plaques.

Main Methods:

• Utilized Ki-67 immunohistochemistry on brain tissue sections from 24 patients.
• Included samples from multiple sclerosis, normal brains, and other neurological disease controls.
• Quantified and characterized proliferating glial cells based on lineage and lesion activity.

Main Results:

• Glial proliferation was markedly elevated in MS lesions compared to control white matter.
• Proliferating oligodendroglial lineage cells were abundant in both active and chronic MS plaques.
• Ki-67 positive macrophage/microglial cells were primarily observed in acute MS lesions.

Conclusions:

• The MS brain demonstrates a substantial capacity for generating new oligodendrocytes over extended periods, even in chronic lesions.
• Increased oligodendroglial proliferation suggests a potential for remyelination in MS.
• Further research is needed to identify the microenvironmental factors driving oligodendrocyte generation and loss in MS plaques.